Molecure S.A. (WSE: MOC)
Poland
· Delayed Price · Currency is PLN
11.02
+1.24 (12.58%)
Nov 20, 2024, 2:45 PM CET
Molecure Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Net Income | -30.75 | -28.37 | -35.95 | -13.64 | 67.96 | -4.17 | Upgrade
|
Depreciation & Amortization | 4.76 | 4.11 | 3.86 | 2.87 | 2.53 | 2.23 | Upgrade
|
Other Amortization | 0.22 | 0.11 | 0.08 | 0.05 | 0.05 | 0.07 | Upgrade
|
Asset Writedown & Restructuring Costs | -1.39 | -1.39 | 0.05 | -2.63 | -2.36 | -2.07 | Upgrade
|
Stock-Based Compensation | - | - | 0.44 | 2.84 | - | 1.4 | Upgrade
|
Other Operating Activities | -1.04 | -3.66 | -7.5 | -1.15 | -1.89 | -1.91 | Upgrade
|
Change in Accounts Receivable | 0.63 | 7.65 | 4.53 | -0.63 | -12.39 | -0.15 | Upgrade
|
Change in Unearned Revenue | 0.02 | 0.01 | -0.32 | -1.99 | 2.33 | - | Upgrade
|
Change in Other Net Operating Assets | -5.24 | -1.74 | 0.69 | 0.78 | 1.21 | -2.51 | Upgrade
|
Operating Cash Flow | -32.79 | -23.29 | -34.13 | -13.5 | 57.44 | -7.11 | Upgrade
|
Capital Expenditures | -0.84 | -0.36 | -3.32 | -2.45 | -2.09 | -0.36 | Upgrade
|
Sale of Property, Plant & Equipment | 0.05 | 0.02 | 0.05 | 0.01 | 0.03 | 0.04 | Upgrade
|
Sale (Purchase) of Intangibles | -27.37 | -33.53 | -6.72 | -16.38 | 10.63 | -34.53 | Upgrade
|
Other Investing Activities | 0 | - | - | - | - | - | Upgrade
|
Investing Cash Flow | -28.15 | -33.87 | -9.99 | -18.82 | 8.58 | -34.85 | Upgrade
|
Long-Term Debt Issued | - | 0.58 | 0.27 | 0.73 | - | 1.07 | Upgrade
|
Total Debt Issued | 0.52 | 0.58 | 0.27 | 0.73 | - | 1.07 | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | -1.44 | - | Upgrade
|
Total Debt Repaid | - | - | - | - | -1.44 | - | Upgrade
|
Net Debt Issued (Repaid) | 0.52 | 0.58 | 0.27 | 0.73 | -1.44 | 1.07 | Upgrade
|
Issuance of Common Stock | - | 49.1 | 0.12 | 4.84 | - | - | Upgrade
|
Other Financing Activities | 4.03 | 5.85 | 7.31 | 8.29 | 21.88 | 23.06 | Upgrade
|
Financing Cash Flow | 4.55 | 55.53 | 7.7 | 13.86 | 20.45 | 24.13 | Upgrade
|
Net Cash Flow | -56.4 | -1.63 | -36.42 | -18.46 | 86.46 | -17.82 | Upgrade
|
Free Cash Flow | -33.63 | -23.65 | -37.45 | -15.95 | 55.35 | -7.47 | Upgrade
|
Free Cash Flow Margin | -2209.72% | -647.54% | -498.43% | -1365.60% | 44.31% | -370.91% | Upgrade
|
Free Cash Flow Per Share | -2.00 | -1.40 | -2.67 | -1.14 | 4.07 | -0.55 | Upgrade
|
Levered Free Cash Flow | -47.12 | -43.06 | -24.26 | -22.75 | 46.93 | -35.74 | Upgrade
|
Unlevered Free Cash Flow | -47.09 | -43.03 | -24.25 | -22.75 | 46.94 | -35.74 | Upgrade
|
Change in Net Working Capital | 3.92 | -6.75 | -4.95 | 1.07 | 10.25 | 1.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.